Using clinical study reports obtained from the European Medicines Agency (EMA) and GlaxoSmithKline from 2014 to 2017, study authors Lars Jørgensen, Peter Gøtzsche and Tom Jefferson set forth to assess the benefits and harms of the HPV vaccine. 

The researchers looked at twenty-four of 50 eligible clinical study reports containing 58,412 pages of 22 trials and 2 follow-up studies including 95,670 participants: 79,102 females and 16,568 males age 8–72. 

The newly published research from Gøtzsche and co-authors found more of the same shoddy research behavior reporting:

"Serious harms were incompletely reported for 72% of participants. Nearly all control participants received active comparators. No clinical study report included complete case report forms." 

Furthermore, the researchers found: 

"the HPV vaccines increased serious nervous system disorders and general harms."